Tofajak is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Tofajak safe for pregnant women?
Pregnant women may get severe side effects after taking Tofajak. If you are pregnant, do not take Tofajak without a doctor's advice.
Is the use of Tofajak safe during breastfeeding?
Tofajak may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Tofajak on the Kidneys?
Tofajak may have mild side effects on the kidneys.
What is the effect of Tofajak on the Liver?
Tofajak may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Tofajak on the Heart?
Using Tofajak does not have any harmful effects on the heart.
Tofajak should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Tofajak unless your doctor advises you to do so -
Is this Tofajak habit forming or addictive?
Tofajak is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tofajak you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Tofajak should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Tofajak is not used to treat mental disorders.
Interaction between Food and Tofajak
Due to a lack of research, nothing can be said about the consequences of taking Tofajak together with food.
Interaction between Alcohol and Tofajak
Due to lack of research, there is no information about the side effects of taking Tofajak with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xeljanz® (tofacitinib)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1213-1214
